Avenue Therapeutics Stock Investor Sentiment
| ATXI Stock | USD 2.06 0.02 0.98% |
Under 52% of Avenue Therapeutics' investor base is interested to short. The analysis of overall sentiment of trading Avenue Therapeutics stock suggests that many investors are impartial at this time. Avenue Therapeutics' investing sentiment shows overall attitude of investors towards Avenue Therapeutics.
Avenue |
Avenue Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Avenue Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Avenue Therapeutics that are available to investors today. That information is available publicly through Avenue media outlets and privately through word of mouth or via Avenue internal channels. However, regardless of the origin, that massive amount of Avenue data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Avenue Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Avenue Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Avenue Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Avenue Therapeutics alpha.
Avenue Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Insider Trading | 09/09/2024 |
2 | Acquisition by Charles Faith L. of 30000 shares of Avenue Therapeutics at 2.46 subject to Rule 16b-3 | 09/23/2024 |
3 | Acquisition by Oltmans Curtis Gale of 30000 shares of Avenue Therapeutics at 2.46 subject to Rule 16b-3 | 09/25/2024 |
4 | Acquisition by Kranzler Jay D of tradable shares of Avenue Therapeutics at 2.4 subject to Rule 16b-3 | 09/27/2024 |
5 | Acquisition by Kranzler Jay D of 497 shares of Avenue Therapeutics at 2.5 subject to Rule 16b-3 | 09/30/2024 |
6 | Avenue Therapeutics stock hits 52-week low at 2.17 - Investing.com | 10/04/2024 |
7 | Acquisition by Paley Jeffrey of 14663 shares of Avenue Therapeutics subject to Rule 16b-3 | 10/11/2024 |
8 | Disposition of tradable shares by Kranzler Jay D of Avenue Therapeutics at 2.24 subject to Rule 16b-3 | 11/05/2024 |
9 | Avenue Therapeutics director Jay Kranzler sells 136 in stock | 11/08/2024 |
10 | Acquisition by David Jin of 250000 shares of Avenue Therapeutics at 1.14 subject to Rule 16b-3 | 11/22/2024 |
Complementary Tools for Avenue Stock analysis
When running Avenue Therapeutics' price analysis, check to measure Avenue Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avenue Therapeutics is operating at the current time. Most of Avenue Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avenue Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avenue Therapeutics' price. Additionally, you may evaluate how the addition of Avenue Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |